Lack of effect of a moderate hypocaloric diet on visfatin levels in morbid obese patients: Relationship with insulin resistance

European Review for Medical and Pharmacological Sciences

Volumn 14, Issue 12, 2010, Pages 1031-1036

  De Luis, Daniel A ^a   Gonzalez Sagrado, M ^a   Conde, R ^a   Aller, R ^a   Izaola, O ^a   Castro, M J ^a   Romero, E ^a  

^a UNIVERSITY OF VALLADOLID   (Spain)

Author keywords

Adipocytokine; Hypocaloric diet; Morbid obesity; Visfatin

Indexed keywords

C REACTIVE PROTEIN; CHOLESTEROL; GLUCOSE; INSULIN; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE;

ADULT; ARTICLE; BODY MASS; BODY WEIGHT; CHEMICAL ANALYSIS; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN RESISTANCE; LOW CALORY DIET; MALE; MORBID OBESITY; PROTEIN BLOOD LEVEL; SYSTOLIC BLOOD PRESSURE; WAIST CIRCUMFERENCE; WEIGHT REDUCTION;

ADULT; AGED; BIOLOGICAL MARKERS; BLOOD GLUCOSE; C-REACTIVE PROTEIN; CALORIC RESTRICTION; CHOLESTEROL; CYTOKINES; DIET, REDUCING; FEMALE; HUMANS; INSULIN; INSULIN RESISTANCE; MALE; MIDDLE AGED; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; OBESITY, MORBID; SPAIN; TIME FACTORS; TREATMENT OUTCOME; WEIGHT LOSS;

EID: 79951847974     PISSN: 11283602     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. FANTUZZI G. Adipose tissue, adipokines, and inflammation. J Allergy CLin Immunol 2005; 115: 911-919.
2. MEIER U, GRESSNER AM. Endocrine regulation of energy metabolism: review of pathobiochemical and clinical chemical aspects of leptin, ghrelin, adiponectin and resistin. Clin Chemistry 2004; 50: 1511-1525.
3. FRAYN KN. Subcutaneous and visceral adipose tissue their relation to metabolic syndrome. Endocr Rev 2000; 21: 697-738.
4. OGNJANOVIC S. Genomic organization of the gene coding for human pre-B-cell colony enhancing factor and expression in human fetal membranes. J Mol Endocrinol 2001; 26: 107-117.
5. FUKUHARA A, MATSUDA M, NISHIZAWA M, SAGAWA K, TANAKA M, KISHIMOTO K, MATSUKI Y, MURAKAMI M, ICHISAKA T, MURAKAMI H, WATANABE E, TAKAGI T, AKIYOSHI M, OHTSUBO T, KIHARA S, YAMASHITA S, MAKISHIMA M, FUNAHASHI T, YAMANAKA S, HIRAMATSU R, MATSUZAWA Y, SHIMOMURA I. Visfatin: a protein secreted by visceral fat that mimics the effects of insulin. Science 2005; 307: 426-430.
6. DE LUIS DA, GONZALEZ SAGRADO, CONDE R, ALLER R, IZAOLA O, ROMERO E. Effect of a hypocaloric diet on serum visfatin in obese non-diabetic patients. Nutrition 2008; 24: 517-521.
7. HAIDER DG, SCHINDLES K, SCHALLER G, PRAGER G, WOLTZ M, LUDVIK B. Increased plasma visfatin concentrations in morbidly obese subjects are reduced after gastric banding. J CLin Endocrinol Metab 2006; 91: 1578-1581.
8. MANCO M, FERNANDEZ REAL JM, EQUITANI F, VENDRELL J, VARELA ME, NANNI G, TONDOLO V, CALVANI M, RICART W, MINGRONE G. Effect of massive weight loss on inflammatory adipocytokines and the innate immune system in morbidly obese women, J Clin Endocrinol Metab 2007; 92: 483-490.
9. MATTHEWS DR, HOSKER JP, RUDENSKI AS, NAYLOR BA, TREACHER DF. Homeostasis model assessment: insulin resistance and beta cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-414.
10. FEURER ID, MULLEN JL. Bedside measurement of resting energy expenditure and respiratory quotient via indirect calorimetry. Nutr Clin Pract 1986; 1: 43-49.
11. PICHARD C, SLOSMAN D, HIRSCHEL B, KYLE U. Bioimpedance analysis in patients: an improved method for nutritional follow up. Clin Res 1993; 41: 53-54.
12. MATAIX J, MAÑAS M. Tablas de composición de alimentos españoles. Ed: University of Granada, 2003.
13. BRENDT J, KLÖTING N, KRALISCH S, KOVACS P, FASSHAUER M, SCHÖN M, STUMVOLL M, BLÜHER M. Plasma visfatin concentrations and fat depot specific RNA expression in humans. Diabetes 2005; 54: 2911-2916.
14. LI L, YANG G, LI Q, TANG Y, YAHG M, YANG H, LI K. Changes and relations of circulating visfatin, apelin, and resistin levels in normal, impaired glucose tolerance, and type 2 diabetic subjects. Exp Clin Endocrinol Diabetes 2006; 114: 544-548.
15. DOGRU T,, SONMEZ A, TASCI I, BOZOGLU E, YILMAZ MI, GENC H, ERDEM G, GOK M, BINGOL N, KILIC S, OZGURTAS T, BINGOL S. Plasma visfatin levels in patients with newly diagnosed and untreated type 2 diabetes mellitus and impaired glucose tolerance. Diabetes Res Clin Pract 2007; 76: 24-29.
16. GARCIA FUENTES E, GARCIA ALMEIDA JM, GARCIA ARNES J, GARCIA SERRANO S, RIVAS MARIN J, GALEGO PERALES J et al. Plasma visfatin concentrations in severely obese subjects are increased after intestinal bypass. Obes Surg 2007; 15: 2391-2395
17. KRZYZANOWSKA K, MITTERNMAYER F, KRUGLUGER W, KOPP HO, SCHERNTHANER G. Increase in visfatin after weight loss induced by gastroplastic surgery. Obesity 2006; 14: 1886-1889.
18. KOVACIKOVA M, VITKOVA M, KLIMCAKOVA E, POLAK J, HEJNOVA J, BAJZOVA M. Visfatin expression in subcutaneous adipose tissue of pre-menopausal women: relation to hormones and weight reduction. Eur J Clin Invest 2008; 38: 516-522.
19. HAIDER DG, SCHALLER G, KAPIOTIS S, MAIER C, LUGER A, WOLTZ M. The release of the adipocytokine visfatin is regulated by glucose and insulin. Diabetologia 2006; 49: 1909-1914.
20. WEN Y, WANG HW, WU J, LU HL, HU XF, CIANFLONE K. Effects of fatty acid regulation on vistatin gene expression in adipocytes. Chin Med J 2006; 119: 1701-1708.
21. SUN G, BISHOP J, KHALLILI S, VASDEV S, GILL V, PACE D, FITZPATRICK D, RANDELL E, XIE YG, ZHANG H. Serum visfatin concentrations are positively correlated with serum triacylglycerols and downregulated by overfeeding in healthy young men. Am J Clin Nutr 2007; 85: 399-404.
22. VARMA V, YAO-BORENGASSER A, RASOULI N, BODLES AM, PHANANVANH B, LEE MJ, STARKS T, KERN LM, SPENCER HJ 3RD, MCGEHEE RE JR, FRIED SK, KERN PA. Human visfatin expression: relationship to insulin sensitivity, intramyocellular lipids, and inflammation. J Clin Endocrinol Metab 2007; 92: 666-672.